Silo Pharma, Inc.
SILO
$2.15
-$0.13-5.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 18.00K | 18.00K | 18.00K | 18.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 18.00K | 18.00K | 18.00K | 18.00K |
| Cost of Revenue | -- | 20.70K | 20.70K | 20.70K | 1.50K |
| Gross Profit | -- | -2.70K | -2.70K | -2.70K | 16.60K |
| SG&A Expenses | 630.50K | 578.70K | 477.90K | 605.20K | 547.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 928.90K | 1.61M | 804.60K | 1.17M | 1.27M |
| Operating Income | -928.90K | -1.59M | -786.50K | -1.15M | -1.25M |
| Income Before Tax | -832.80K | -1.65M | -881.50K | -1.11M | -1.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -832.80K | -1.65M | -881.50K | -1.11M | -1.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -832.80K | -1.65M | -881.50K | -1.11M | -1.20M |
| EBIT | -928.90K | -1.59M | -786.50K | -1.15M | -1.25M |
| EBITDA | -926.00K | -1.59M | -783.60K | -1.15M | -1.25M |
| EPS Basic | -0.76 | -1.80 | -0.99 | -1.79 | -2.88 |
| Normalized Basic EPS | -0.53 | -1.13 | -0.62 | -1.12 | -1.80 |
| EPS Diluted | -0.76 | -1.80 | -0.99 | -1.79 | -2.88 |
| Normalized Diluted EPS | -0.53 | -1.13 | -0.62 | -1.12 | -1.80 |
| Average Basic Shares Outstanding | 1.10M | 913.90K | 891.90K | 622.10K | 418.60K |
| Average Diluted Shares Outstanding | 1.10M | 913.90K | 891.90K | 622.10K | 418.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |